Rocket Lab's Moment of Reckoning: Can a Contract Bonanza Finally Translate Into Numbers?

Rocket Lab reports Q2 revenue near $231.6M amid record defense deals, but shares remain 44% below peak as investors await clarity on Iridium acquisition.

The narrative arc of Rocket Lab's 2026 has been written in two registers: the triumphant cadence of contract announcements, and the quieter, more anxious hum of a share price that still sits nearly 44 percent below its May peak. When the company opens its books after the US market close today, investors will be looking for the thread that ties those two stories together.

The consensus estimate calls for second-quarter revenue of roughly $231.6 million, a year-over-year jump of about 60 percent. That figure sits comfortably within the company's own guidance range of $225 million to $240 million, alongside a projected GAAP gross margin of 33 to 35 percent and operating expenses between $138 million and $144 million. The numbers themselves are the easy part — the harder question is whether the recent avalanche of contracts has fundamentally changed the company's trajectory, or merely padded its backlog.

A Fortnight of Firepower

The last few weeks have delivered a drumbeat of wins that would be remarkable for any company in the sector. On August 4, the US Space Force handed Rocket Lab a $397 million award under the Space-Based Airborne Moving Target Indicator program, known as SB-AMTI. The scope goes well beyond launch services: Rocket Lab will develop, launch, and operate a fleet of so-called flatellites — a flat satellite design intended for large constellations, equipped with sensors and low-latency communications links. The payloads are slated to ride on the Neutron rocket, which remains in development, and will be operated from the company's own secure facilities.

That contract followed a $266 million multi-launch agreement with the Space Force announced on July 27 — the largest launch contract in company history, covering twelve suborbital missions from Alaska with options for up to six additional flights. Sandwiched between those two defense wins was a commercial deal with Japanese Earth-observation specialist iQPS for three more dedicated Electron missions, agreed on July 30. The relationship with iQPS has become a recurring theme: the company's 92nd Electron mission, "The Grain Goddess Provides," lifted off on August 6 carrying the QPS-SAR-13 radar satellite into a 575-kilometer orbit — the eighth mission flown for that single customer, with ten more booked through 2030.

The $8 Billion Question

Yet none of these contracts, individually or collectively, matches the scale of the strategic bet announced in June. Rocket Lab's definitive agreement to acquire Iridium Communications — disclosed on June 29 — values the satellite communications provider at roughly $8.0 billion, with Iridium shareholders receiving $54 per share in a cash-and-stock mix. The structure breaks down to $27.00 in cash plus Rocket Lab shares, with the exchange ratio collared between $67.50 and $112.50. The deal is expected to close in mid-2027, subject to Iridium shareholder approval and regulatory clearances.

The acquisition represents the fullest expression yet of Rocket Lab's transformation from launch provider to vertically integrated space and communications group — a shift that the SB-AMTI contract, with its emphasis on building and operating satellites rather than merely transporting them, already foreshadows. For now, though, the transaction remains a valuation factor rather than an operational one; today's quarterly figures will not reflect it.

Insider Sales and the Skeptic's View

Not everyone is reading the same tea leaves. Data compiled over the past 90 days shows insider sales totaling roughly $896 million, with CEO Peter Beck the most prominent seller — though those transactions were executed automatically under a Rule 10b5-1 trading plan established on March 27, 2026, meaning they followed a pre-arranged schedule rather than reflecting any fresh decision about the stock's prospects. The Equatorial Trust, an entity linked to Beck, disposed of 3,275,779 shares between July 6 and July 8 through open-market sales.

The timing of those sales has given ammunition to skeptics, particularly since they coincided with a period of volatility. But the market's most recent verdict has been decidedly optimistic: the stock climbed 8.65 percent on Friday to close at €71.60 following the Space Force announcement, and has advanced roughly 17 percent over the past week. At the current price of €74.60, the shares are up 3.90 percent on the day and have gained 21.90 percent over the last seven trading sessions — now trading 5.85 percent above their 200-day moving average.

The Distance Still to Travel

The recovery, however forceful, has not erased the damage done earlier in the year. The stock remains roughly 44.25 percent below its 52-week high, reached in May — a gap that speaks to how much skepticism was priced in during the spring sell-off, and how far the recent contract flow still has to go to restore the previous valuation level.

Analyst sentiment has been cautiously constructive. KeyBanc Capital Markets upgraded Rocket Lab from Sector Weight to Overweight in mid-June, setting a price target of $135 — though that call predates the current earnings season and reflects conditions at the time rather than a fresh assessment.

What today's report will ultimately test is whether the operational momentum can be converted into financial performance at the pace the market expects. The company has spent the summer accumulating contracts, announcing a transformative acquisition, and watching its stock swing between euphoria and doubt. The second-quarter numbers, and the commentary that accompanies them, will offer the first clear signal of which force wins the next round.